Development and Initial Testing of a Modified UroVysion-Based Fluorescence In Situ Hybridization Score for Prediction of Progression in Bladder Cancer.

CONCLUSIONS: UFS can indicate an increased risk for progression into muscle-invasive disease in patients with NMIUC and improves prognostic accuracy of the current clinical risk assessment systems. PMID: 31732739 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31732739?dopt=Abstract

Source: American Journal of Clinical Pathology - November 15, 2019 Category: Pathology Authors: Kocsmár I, Pajor G, Gyöngyösi B, Székely E, Varga M, Kocsmár É, Kenessey I, Beöthe T, Süle N, Majoros A, Szendrői A, Nyírády P, Kiss A, Riesz P, Gábor L Tags: Am J Clin Pathol Source Type: research